SCHEMBL6028989

SCHEMBL6028989

CCN1CCN(CCOc2ccc(-c3cc4cccc(C(N)=O)c4[nH]3)cc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 2/20 0.51
DHODH Q02127 1/20 0.51
DRD3 P35462 6/20 0.47
DRD2 P14416 3/20 0.47
ALDH1A1 P00352 2/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
KDM4E B2RXH2 1/20 0.46
GAA P10253 1/20 0.46
HRH3 Q9Y5N1 1/20 0.45
CHEK1 O14757 1/20 0.44
TBK1 Q9UHD2 1/20 0.44
CYP4F2 P78329 2/20 0.44
CYP4A11 Q02928 2/20 0.44
MAPK1 P28482 1/20 0.44
RAB9A P51151 1/20 0.44
HTR1A P08908 2/20 0.43
CHEK2 O96017 1/20 0.43
ADRB1 P08588 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6028431 0.94 PARP1 (0.51) PARP1DHODHDRD3DRD2HRH3
SCHEMBL6028855 0.93 PARP1 (0.52) PARP1DHODHDRD3DRD2ALDH1A1
SCHEMBL6029990 0.91 PARP1 (0.60) PARP1DHODHDRD3DRD2HRH3
SCHEMBL6029382 0.89 PARP1 (0.52) PARP1DHODHDRD3DRD2ALDH1A1
SCHEMBL6028915 0.88 PARP1 (0.47) PARP1DHODHDRD3DRD2HRH3
SCHEMBL6029389 0.88 MAOB (0.50) PARP1DHODHDRD3DRD2ALDH1A1
SCHEMBL5072000 0.85 PARP1 (0.53) PARP1DHODHDRD3DRD2ALDH1A1
SCHEMBL6029241 0.84 DHODH (0.46) PARP1DHODHDRD3DRD2GAA
SCHEMBL6029678 0.83 AURKA (0.50) PARP1DHODHMEN1KMT2AKDM4E
SCHEMBL6029191 0.80 TNKS (0.58) PARP1DHODHALDH1A1KDM4ECHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7087637-B2 Substituted indoles which are PARP inhibitors BASF AG (DE) 2006-08-08 US disclosed
US-20040067949-A1 Substituted indoles which are parp inhibitors ABBVIE DEUTSCHLAND GMBH & CO KG (DE) 2004-04-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040067949-A1 Substituted indoles which are parp inhibitors PARP1, PARP2, PARP12 PARP1 1/4885DHODH 674/4885DRD3 1182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.